Development of Tinidazole Loaded Polymeric Nanoparticles Formulation and its Characterization

Abstract

Introduction: The development of safe drug delivery systems for a therapeutic agent with less side effects and more bioavailability to the targeted site is very vital in drugs formulation. Tinidazole (TZ) is a drug used to treat giardiasis, amebiasis for colon infections and other infections also such as trichomoniasis, bacterial vaginosis. But the oral bioavailability for the current using drugs low. So, the current study was aimed to develop colon targeted drug delivery system for Tinidazole (TZ) with polymeric nanoparticles (NPs). Methodology: The nanoparticles formulations of TZ were prepared with modified ionic gelation method using chitosan and hydroxypropyl methylcellulose phthalate (HPMCP) are in different combinations by magnetic stirring method followed by temperature modulated solidification. The solvent evaporation method applied to coat TZ nanoparticles with Eudragit S100. The prepared TZ nanoparticle were studied to evaluate physiochemical properties, In-vitro drug release, mucopenetration and In-vivo mucoadhesive studies were carried out. Results: The results of study indicate, 1:1 ratio of chitosan and HPMCP formulation of nanoparticles provides better spatial interaction between them and TZ with spherical porous and the particles size was diverging between 202 - 236 nm. In vitro release of TZ followed Higuchi and first order equations better than zero order equation. The drug release results of nanoparticles formulations of TZ indicate that the NPs have potential as a drug delivery system compare to uncoated TZ and coated nanoparticles have comparatively less mucoadhesive detachment force. Conclusion: In conclusion, the study was an evidence to use nanoparticles in colon targeted drug delivery systems for better bioavailability of drugs at targeted site and the biodistribution properties of drugs using nanoparticle will be depend on their composition, particle size and their adhesive abilities.